RhumbLine Advisers’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,212
Closed -$250K 3165
2022
Q1
$250K Buy
2,212
+518
+31% +$60K ﹤0.01% 2698
2021
Q4
$162K Buy
1,694
+162
+11% +$14.6K ﹤0.01% 2879
2021
Q3
$136K Buy
1,532
+116
+8% +$11.4K ﹤0.01% 2963
2021
Q2
$174K Buy
+1,416
New +$196K ﹤0.01% 2932
2019
Q2
Sell
-90
Closed -$7K 2989
2019
Q1
$7K Sell
90
-4
-4% -$351 ﹤0.01% 2939
2018
Q4
$7K Buy
94
+30
+47% +$3.51K ﹤0.01% 2974
2018
Q3
$7K Sell
64
-3
-4% -$7.83K ﹤0.01% 2918
2018
Q2
$183K Buy
+67
New +$155K ﹤0.01% 2756
2017
Q2
Sell
-64
Closed -$103K 2936
2017
Q1
$103K Buy
64
+3
+5% +$5.49K ﹤0.01% 2775
2016
Q4
$107K Sell
61
-16
-21% -$35K ﹤0.01% 2788
2016
Q3
$188K Buy
77
+1
+1% +$2.47K ﹤0.01% 2700
2016
Q2
$188K Buy
76
+27
+55% +$88.7K ﹤0.01% 2770
2016
Q1
$177K Buy
49
+4
+9% +$13.9K ﹤0.01% 2769
2015
Q4
$208K Buy
45
+9
+25% +$29.4K ﹤0.01% 2776
2015
Q3
$57K Buy
36
+2
+6% +$10K ﹤0.01% 2988
2015
Q2
$289K Buy
+34
New +$324K ﹤0.01% 2680

Other funds holding IMUX